Motor function performance in individuals with RYR1-related myopathies

Muscle Nerve. 2019 Jul;60(1):80-87. doi: 10.1002/mus.26491.

Abstract

Introduction: The objective of this study was to obtain a 6-month natural history of motor function performance in individuals with RYR1- related myopathy (RYR1-RM) by using the Motor Function Measure-32 (MFM-32) and graded functional tests (GFT) while facilitating preparation for interventional trials.

Methods: In total, 34 participants completed the MFM-32 and GFTs at baseline and 6-month visits.

Results: Motor deficits according to MFM-32 were primarily observed in the standing and transfers domain (D1; mean 71%). Among the GFTs, participants required the most time to ascend/descend stairs (>7.5 s). Functional movement, determined by GFT grades, was strongly correlated with MFM-32 (D1; r ≥ 0.770, P < 0.001). Motor Function Measure-32 and GFT scores did not reflect any change in performance between baseline and 6-month visits.

Discussion: The MFM-32 and GFTs detected motor impairment in RYR1-RM, which remained stable over 6 months. Thus, these measures may be suitable for assessing change in motor function in response to therapeutic intervention. Muscle Nerve 60: 80-87, 2019.

Keywords: RYR1; GFT; MFM; disease progression; motor function.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Disease Progression
  • Female
  • Humans
  • Male
  • Middle Aged
  • Movement / physiology*
  • Myopathies, Structural, Congenital / genetics
  • Myopathies, Structural, Congenital / physiopathology*
  • Myopathy, Central Core / genetics
  • Myopathy, Central Core / physiopathology
  • Ophthalmoplegia / genetics
  • Ophthalmoplegia / physiopathology
  • Ryanodine Receptor Calcium Release Channel / deficiency
  • Ryanodine Receptor Calcium Release Channel / genetics*
  • Young Adult

Substances

  • Ryanodine Receptor Calcium Release Channel

Supplementary concepts

  • Minicore Myopathy with External Ophthalmoplegia